Wael M. Samy

Wael M. Samy

Auto-generated profile, based on publicly available information

Wael M. Samy

Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
AEAhmed O. Elzoghby
Ahmed O. Elzoghby
WSWael M. Samy
Wael M. Samy
NENazik A. Elgindy
Nazik A. Elgindy

1 July 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
AEAhmed O. Elzoghby
Ahmed O. Elzoghby
WSWael M. Samy
Wael M. Samy
NENazik A. Elgindy
Nazik A. Elgindy

1 August 2011 in Journal of Controlled Release
Verified
Journal Article
Closed access
AEAhmed O. Elzoghby
Ahmed O. Elzoghby
WEWael S. Abo El-Fotoh
Wael S. Abo El-Fotoh
NENazik A. Elgindy
Nazik A. Elgindy

1 May 2013 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AEAhmed Elzoghby
Ahmed Elzoghby
MHMaged W Helmy
Maged W Helmy
WSWael M Samy
Wael M Samy
ELElgindy
Elgindy
A novel particulate delivery matrix based on ionically crosslinked casein (CAS) nanoparticles was developed for controlled release of the poorly soluble anticancer drug flutamide (FLT). Nanoparticles were fabricated via oil-in-water emulsification then stabilized by ionic crosslinking of the positively charged CAS molecules below their isoelectric point, with the polyanionic crosslinker sodium tripolyphosphate. With the optimal preparation conditions, the drug loading and incorporation efficiency achieved were 8.73% and 64.55%, respectively. The nanoparticles exhibited a spherical shape with a size below 100 nm and a positive zeta potential (+7.54 to +17.3 mV). FLT was molecularly dispersed inside the nanoparticle protein matrix, as revealed by thermal analysis. The biodegradability of CAS nanoparticles in trypsin solution could be easily modulated by varying the sodium tripolyphosphate crosslinking density. A sustained release of FLT from CAS nanoparticles for up to 4 days was observed, depending on the crosslinking density. After intravenous administration of FLT-CAS nanoparticles into rats, CAS nanoparticles exhibited a longer circulation time and a markedly delayed blood clearance of FLT, with the half-life of FLT extended from 0.88 hours to 14.64 hours, compared with drug cosolvent. The results offer a promising method for tailoring biodegradable, drug-loaded CAS nanoparticles as controlled, long-circulating drug delivery systems of hydrophobic anticancer drugs in aqueous vehicles.

8 November 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
AEAhmed O. Elzoghby
Ahmed O. Elzoghby
WSWael M. Samy
Wael M. Samy
NENazik A. Elgindy
Nazik A. Elgindy

1 August 2013 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AEAhmed O. Elzoghby
Ahmed O. Elzoghby
MHMaged W. Helmy
Maged W. Helmy
WSWael M. Samy
Wael M. Samy
NENazik A. Elgindy
Nazik A. Elgindy